Literature DB >> 19503979

The use of azythromycin and N-methyl glucamine for the treatment of cutaneous Leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL6 mice.

Raimunda Nonata Ribeiro Sampaio1, Iris Campos Lucas, Arnoldo Velloso da Costa Filho.   

Abstract

BACKGROUND: The first choice treatment for cutaneous Leishmaniasis is N-methyl glucamine: it has high toxicity, requires parenteral administration and cure is not always reached. Azythromycin showed in vitro action and controversial results in humans with the disease.
OBJECTIVE: To verify if the association of N-methyl-glucamine - azythromycin is more effective than N-methyl-glucamine alone for the treatment of experimental Leishmaniasis.
METHODS: Twenty-five C57BL/6 mice were inoculated with L. (L.) amazonensis strain and divided into two groups. One group was treated with 400 mgSbV/kg/day of N-methyl glucamine and 200mg/kg/day of azythromycin for 20 days and the other group received the same dose of N-methyl glucamine alone during the same period of time. Clinical and parasitological evaluations were submitted to statistical analyses.
RESULTS: There was no statistical difference in clinical analysis, in amastigotes investigation and in cultures. There were significant differences in cultures using limiting dilution, which showed lower efficacy of the association N-methyl glucamine -azythromycin.
CONCLUSION: N-methyl glucamine-azythromycin association was not more effective than N-methyl glucamine alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19503979     DOI: 10.1590/s0365-05962009000200004

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  2 in total

Review 1.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

2.  American tegumentary leishmaniasis - a case of therapeutic challenge.

Authors:  Daíne Vargas Couto; Gunter Hans Filho; Marcelo Zanolli Medeiros; Carolina Faria Santos Vicari; Aline Blanco Barbosa; Luiz Carlos Takita
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.